2010
DOI: 10.1016/j.nlm.2010.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

8
81
1
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 142 publications
(91 citation statements)
references
References 69 publications
8
81
1
1
Order By: Relevance
“…Quercetin (QU), for instance, had an antioxidative ability to eliminate free radicals and could ameliorate cognitive and memory dysfunction. [9][10][11][12] However, problems, including low solubility in the blood, rapid metabolism in the intestine and liver, and low uptake in the brain, have considerably restrained clinical application of QU. 13 Hence, a modification with bioactive molecules to mediate the brain distribution of QU can be a possible approach to alleviating AD progression.…”
Section: Introductionmentioning
confidence: 99%
“…Quercetin (QU), for instance, had an antioxidative ability to eliminate free radicals and could ameliorate cognitive and memory dysfunction. [9][10][11][12] However, problems, including low solubility in the blood, rapid metabolism in the intestine and liver, and low uptake in the brain, have considerably restrained clinical application of QU. 13 Hence, a modification with bioactive molecules to mediate the brain distribution of QU can be a possible approach to alleviating AD progression.…”
Section: Introductionmentioning
confidence: 99%
“…Increased ROS production exerts toxic effects on membrane polyansaturated phospholipids, resulting in generation of toxic products such as MDA (Arnal et al 2010). Diabetes, the most common endocrine disorder, characterized by increased blood glucose levels resulting from defective insulin secretion and its complications are associated with increased oxidative stress (Bhutada et al 2010;Amin et al 2015). In the STZ-induced diabetes, MDA levels increase Apaydın et al 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…At 72 h following the STZ injection, blood samples were collected from the tail vein to measure blood glucose levels. Rats with fasting blood glucose levels >16.7 mmol/l were considered successful DM models and were used for further investigation (59). The normal rats who did not accept the treatment of STZ were randomly divided into two groups: The control group (treated with normal saline injection every day), and the H 2 S-c2 group (normal rats treated with a high concentration of NaHS, c2=100 µmol/kg; received i.p., daily).…”
Section: Methodsmentioning
confidence: 99%